Thalidomide downregulates transcript levels of GC-rich promoter genes in multiple myeloma.

被引：0
|
作者：
Uziel, O
Shapira, A
Radnay, J
Lahav, M
Lishner, M
机构：
[1] Sapir Med Ctr, Oncogenet Lab, Kefar Sava, Israel
[2] Sapir Med Ctr, Hematol Lab, Kefar Sava, Israel
[3] Sapir Med Ctr, Dept Med, Kefar Sava, Israel
[4] Tel Aviv Univ, IL-69978 Tel Aviv, Israel
来源：
BLOOD | 2001年 / 98卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1573
引用
收藏
页码：373A / 374A
页数：2
相关论文
共 50 条
  • [41] Low-dose thalidomide and dexamethasone improves survival in advanced multiple myeloma.
    Palumbo, A
    Bertola, A
    Cavallo, F
    Falco, P
    Bringhen, S
    Giaccone, L
    Musto, P
    Pregno, P
    Boccadoro, M
    BLOOD, 2002, 100 (11) : 211A - 211A
  • [42] Yeast Protein Nhp6A Binds to Short GC-Rich Genes
    Gerasimov E.S.
    Gerasimova N.S.
    Kozlova A.L.
    Studitsky V.M.
    Moscow University Biological Sciences Bulletin, 2018, 73 (2) : 88 - 91
  • [43] Thalidomide plus M2 chemotherapy in the treatment of refractory multiple myeloma.
    Meng, HT
    Jin, J
    Mai, WY
    BLOOD, 2002, 100 (11) : 387B - 387B
  • [44] Thalidomide is able to improve the outcome in patients carrying the high producer haplotype of the interleukin-10 gene promoter in multiple myeloma.
    Neben, K
    Mytilineos, J
    Kraemer, A
    Moehler, TM
    Preiss, A
    Ho, AD
    Opelz, G
    Goldschmidt, H
    BLOOD, 2002, 100 (11) : 170A - 170A
  • [45] Thalidomide plus CED chemotherapy as salvage therapy in poor prognosis multiple myeloma.
    Moehler, TM
    Neben, K
    Hawighorst, H
    Egerer, G
    van Kaick, G
    Ho, AD
    Goldschmidt, H
    BLOOD, 2000, 96 (11) : 290B - 290B
  • [46] Yeast protein Nhp6A binds to short GC-rich genes
    Gerasimov, E.
    Gerasimova, N.
    Studitsky, V.
    FEBS OPEN BIO, 2018, 8 : 145 - 145
  • [47] Thalidomide plus CED-chemotherapy in patients with poor prognosis multiple myeloma.
    Moehler, TM
    Neben, K
    Egerer, G
    Punzel, M
    Schmier, J
    Cremer, F
    Goldschmidt, H
    Ho, AD
    BLOOD, 1999, 94 (10) : 124A - 125A
  • [48] Thalidomide as maintenance therapy in the post-transplantation setting in patients with multiple myeloma.
    Santos, E
    Goodman, M
    Byrnes, JJ
    Fernandez, HF
    BLOOD, 2002, 100 (11) : 426B - 426B
  • [49] The mouse chromogranin a promoter is regulated by gastrin through an upstream GC-rich sequence.
    Hocker, M
    Wu, HJ
    Nicholls, P
    OConnor, DT
    Wang, TC
    GASTROENTEROLOGY, 1996, 110 (04) : A1081 - A1081
  • [50] Osteoprotegerin levels are increased in serum of patients with multiple myeloma.
    Corso, A
    Dovio, A
    Sartori, ML
    Rusconi, C
    Klersy, C
    Mangiacavalli, S
    Zappasodi, P
    Varettoni, M
    Angeli, A
    Lazzarino, M
    BLOOD, 2003, 102 (11) : 367B - 367B
12345